Table Of Content

Enkelmann R: Alprazolam versus buspir- Contents of volume 105 one in the treatment of outpatients with generalized anxiety disorder 428 No 1: pp 1-144 published August 19, 1991 Ericsson M — Clark D No 2: pp 145-302 published September 26, 1991 Ervin FR > Zacchia C No 3: pp 303-446 published October 9, 1991 Evenden JL: Effects of chlordiazepoxide, No 4: pp 447-586 published October 28, 1991 morphine and amphetamine on responding suppressed by different levels of electric shock in the pigeon are rate dependent 253 Evoniuk GE, Hertzman RP, Skolnick P: A rapid method for evaluating the behavioral effects of phencyclidine-like disso- Aaes-Jo@rgensen T — Kistrup K disrupts sensorimotor gating of startle ciative anesthetics in mice 125 Abe E: Reversal effect of DM-9384 on in the rat 347 scopolamine-induced acetylcholine de- Campling GM - Ellis PM Fagan D, Scott DB, Mitchell M, Tiplady pletion in certain regions of the mouse Castellano C > Cabib S B: Effects of remoxipride on measures brain 310 Cestari V > Cabib S of psychological performance in healthy Aghajanian GK — Rasmussen K Chan K > Dambisya YM volunteers 225 Alvir J > Robinson D Chau A > Khanna JM Fagioli S, Rossi-Arnaud C, Ammassari- Ammassari-Teule M — Fagioli S Cheetham SC — De Paermentier F Teule M: Open field behaviours and Andrews N -= File SE Cicero TJ — Wozniak DF spatial learning performance in C57BL/ Antkiewicz-Michaluk L, Romanska I, Mi- Clark D, Furmidge LJ, Petry N, Tong Z-Y, 6 mice: early stage effects of chronic chaluk J, Vetulani J: Role of calcium Ericsson M, Johnson D: Behavioural GM1 ganglioside administration 209 channels in effects of antidepressant profile of partial D2 dopamine receptor Feldon J, Weiner |: Effects of haloperidol drugs on responsiveness to pain 269 agonists. 1. Atypical inhibition of d-am- on the multitrial partial reinforcement Audi EA, Oliveira RMW de, Graeff FG: phetamine-induced locomotor hyper- extinction effect (PREE): evidence for Microinjection of propranolol into the activity and stereotypy 381 neuroleptic drug action on nonreinfor- dorsal periaqueductal gray causes an Colle LM, Wise RA: Circling induced by cement but not on reinforcement 407 anxiolytic effect in the elevated plus- intra-accumbens amphetamine _injec- Feyerabend C — Srivastava ED maze antagonized by ritanserin 553 tions 157 Fibiger HC + Nomikos GG Avery J — Lifshitz K Cook L —> Holtzman SG File SE, Andrews N: Low but not high Azari NP: Effects of glucose on memory Cooper TB — Lifshitz K doses of buspirone reduce the anxio- processes in young adults 521 Cooper T > Robinson D genic effects of diazepam withdrawal Cowen PJ — Ellis PM 578 Ball DM, Glue P, Wilson S, Nutt DJ: Cowen PJ — Walsh AE Filibeck U -+ Cabib S Pharmacology of saccadic eye move- Crompton MR — De Paermentier F Fleischhacker WW, Miller CH, Schett P, ments in man. 1. Effects of the benzo- Cross AJ — Murray TK Barnas C, Ehrmann H: The Hillside Ak- diazepine receptor ligands midazolam Cunningham CL, Hallett CL, Niehus DR, athisia Scale: a reliability comparison of and flumazenil 361 Hunter JS, Nouth L, Risinger FO: As- the English and German versions 141 Ball DM — Glue P sessment of ethanol’s hedonic effects in Fleishaker JC, Smith TC, Friedman H, Barnas C — Fleischhacker WW mice selectively bred for sensitivity to Phillips JP: N-desmethyladinazolam Barry J de > Mathis C ethanol-induced hypothermia 84 pharmacokinetics and behavioral ef- Battig K > Roth N Curran HV: Benzodiazepines, memory and fects following administration of 10— Beninger RJ — Mazurski EJ mood: areview 1 50 mg oral doses in healthy volunteers Berendsen HHG, Broekkamp CLE: Atten- 181 uation of 5-HT,, and 5-HT> but not 5- Dambisya YM, Chan K, Wong CL: Role Fortmann SP = Killen JD HT,c receptor mediated behaviour in of adrenoceptors in the potentiation of Fowler SC —> Skjoldager P rats following chronic treatment with 5- opioid antinociception by ephedrine Friedman H — Fleishaker JC HT receptor agonists, antagonists or and phenylpropanolamine in mice 563 Fueg A > Weiss GF anti-depressants 219 Damsma G > Nomikos GG Furmidge LJ > Clark D Boomsma F —> Tulen JHM Davis M > Kehne JH Bossert S + Wiegand M De Paermentier F, Cheetham SC, Cromp- Garattini S — Sarati S Boulis NM — Kehne JH ton MR, Katona CLE, Horton RW: Brain Gartside SE — Ellis PM Bradshaw CM — Wogar MA B-adrenoceptor binding sites in de- Genovese RF, Lu X-CM: Effects of MK- Breeding M — Sanders-Bush E pressed suicide victims: effects of anti- 801 stereoisomers on schedule-con- Brent PJ: Similar behavioural effects of depressant treatment 283 trolled behavior in rats 477 sigma agonists and PCP-like non-com- Dement WC — Edgar DM Gerlach J > Kistrup K petitive NMDA antagonists in guinea- Dickinson SL — Jackson HC Geyer MA — Caine SB pigs 421 Geyer MA — Mansbach RS Broekkamp CLE —> Berendsen HHG Eaton-Williams P + Rusted JM Geyer MA — Mittman SM Buchen D —> Weiss GF Edgar DM, Seidel WF, Dement WC: Tria- Gibert-Rahola J ~ Maldonado R zolam-induced sleep in the rat: influ- Glue P, White E, Wilson S, Ball DM, Nutt Cabib S, Castellano C, Cestari V, Filibeck ence of prior sleep, circadian time, and DJ: Pharmacology of saccadic eye U, Puglisi-Allegra S: D1 and D2 recep- light/dark cycles 374 movements in man. 2. Effects of the a2- tor antagonists differently affect co- Ehrmann H — Fleischhacker WW adrenoceptor ligands idazoxan and caine-induced locomotor hyperactivity Elbert T + Schweizer R clonidine 368 in the mouse 335 Ellis PM, Gartside SE, Ware CJ, Campling Glue P — Ball DM Caccia S — Sarati S GM, Cowen PJ: Does metergoline se- Gold PE —> Walker DL Caine SB, Geyer MA, Swerdlow NR: Car- lectively attenuate 5-HT mediated pro- Graeff FG — Audi EA bachol infusion into the dentate gyrus lactin release? 129 Graff JT > Mattingly BA IV Grahame-Smith DG — Silverstone PH Kalant H — Khanna JM vedra MC, Leonsegui |, Gibert-Rahola Green AR > Murray TK Kameyama T > Tohyama K J: Influence of different benzodiaze- Grey C > Walker DL Katona CLE —> De Paermentier F pines on the experimental morphine ab- Guiso G — Sarati S Katz JL, Sharpe LG, Jaffe JH, Shores El, stinence syndrome 197 Gupta U: Differential effects of caffeine Witkin JM: Discriminative stimulus ef- Mansbach RS, Geyer MA: Parametric de- on free recall after semantic and rhym- fects of inhaled cocaine in squirrel mon- terminants in pre-stimulus modification ing tasks in high and low impulsives keys 317 of acoustic startle: interaction with ke- 137 Kehne JH, Boulis NM, Davis M: Effects tamine 162 Guzman NA — Hernandez L of the phosphodiesterase inhibitor roli- Marek GJ > Hand TH pram on the acoustic startle response Marsden CA > Wright IK inrats 27 Marsden CD — Loschmann P-A Hallett CL > Cunningham CL Hand TH, Marek GJ, Seiden LS: Compari- Kelly PAT > Sharkey J Martin WR > Waia EP son of the effects of mianserin and its Kettinger Ill L — Wozniak DF Mase D - Lifshitz K enantiomers and metabolites on a be- Khanna JM, Kalant H, Sharma H, Chau Masterson JG — Srivastava ED havioral screen for antidepressant activ- A: Initial sensitivity, acute tolerance and Masukawa Y —> Suzuki T ity 453 alcohol consumption in Fischer 344 and Mathis C, Barry J de, Ungerer A: Memory Harro J > Vasar E Long Evans rats 175 deficits induced by y-L-glutamyl-L-as- Hartgraves SL > Howerton TC Killen JD, Fortmann SP, Newman B, Var- partate and D-2-amino-5-phosphono- Hatton BJ > Mattingly BA ady A: Prospective study of factors in- valerate in a Y-maze avoidance task: re- Hayes AG > Oakley NR fluencing the development of craving lationship to NMDA receptor antago- Hernandez L, Guzman NA, Hoebel BG: associated with smoking cessation nism 546 Bidirectional microdialysis in vivo 191 Mattingly BA, Rowlett JK, Graff JT, Hat- shows differential dopaminergic po- Kinney R + Wiegand M ton BJ: Effects of selective D, and D, tency of cocaine, procaine and lido- Kistrup K, Gerlach J, Aaes-Jorgensen T, dopamine antagonists on the develop- caine in the nucleus accumbens using Larsen N-E: Perphenazine decanoate ment of behavioral sensitization to apo- capillary electrophoresis for calibration and_ cis(z)-flupentixol decanoate in morphine 501 of drug outward diffusion 264 maintenance treatment of schizophrenic Mayerhoff D > Robinson D Hertzman RP — Evoniuk GE outpatients. Serum levels at the mini- Mazurski EJ, Beninger RJ: Effects of se- Heuij VJHM van den > Tulen JHM mum effective dose 42 lective drugs for dopaminergic D1 and Higgins GA, Nguyen P, Joharchi N, Sell- Krieg J-C — Wiegand M D2 receptors on conditioned locomo- ers EM: Effects of 5-HT3 receptor an- Kruk ZL > Stamford JA tion in rats 107 Krystal JH + Rasmussen K McBean DE = SharkeyJ tagonists on behavioural measures of naloxone-precipitated opioid with- Kumor KM > Muntaner C McBride WJ — Stewart RB McGlynn T > Walker DL drawal 322 Hoebel BG > Hernandez L Lang A > Vasar E McNaughton N > Zhu X Hoh A — Lesch KP Lange KW — Loschmann P-A Meyer ER — Wozniak DF Michaluk J > Antkiewicz-Michaluk L Holtzman SG, Cook L, Steinfels GF: Dis- Larsen N-E —> Kistrup K criminative stimulus effects of spirado- Lee KL — Lifshitz K Mico JA > Maldonado R line, a kappa-opioid agonist 447 Leibowitz SF — Weiss GF Miller CH > Fleischhacker WW Horton RW — De Paermentier F Leonsegui | > Maldonado R Miller SA — Howerton TC Howerton TC, Murphy MR, Miller SA, Lesch KP, Hoh A, Schulte HM, Oster- Misawa M — Suzuki T Hartgraves SL: Differential sensitivity of heider M, Muller T: Long-term fluoxe- Mitchell M > Fagan D CNS regions to acetylcholinesterase in- tine treatment decreases 5-HT,, recep- Mittman SM, Geyer MA: Dissociation of hibition following chronic low-dose so- tor responsivity in obsessive-compul- multiple effects of acute LSD on explo- man treatment in the rat 400 sive disorder 415 ratory behavior in rats by ritanserin and Hubner CB, Moreton JE: Effects of selec- Li T-K + Stewart RB propranolol 69 tive D1 and D2 dopamine antagonists Lieberman J > Robinson D Moleman P > Tulen JHM on cocaine self-administration in the Lifshitz K, O’Keeffe RT, Lee KL, Linn GS, Molina VA > Murua VS rat 151 Mase D, Avery J, Lo ES, Cooper TB: Mondadori C > Weiskrantz L HunterJ S > Cunningham CL Effect of extended depot fluphenazine Monteleone P —> lovino M Moreton JE > Hubner CB treatment and withdrawal on social and Miller T + Lesch KP Ichihara K > Tohyama K other behaviors of Cebus apella mon- Muntaner C, Kumor KM, Nagoshi C, Jaffe Insel TR > Winslow JT keys 492 JH: Effects of nifedipine pretreatment lovino M, Steardo L, Monteleone P: |Im- Liljequist S: Evidence that genetic differ- on subjective and cardiovascular re- paired sensitivity of the hypothalamo- ences in habituation and GABAergic sponses to intravenous cocaine in hu- pituitary-thyroid axis to the suppressant mechanisms may be related to sensitivi- mans 37 effect of dexamethasone in elderly sub- ty to ethanol and development of etha- Murphy JM — Stewart RB jects 481 nol tolerance in mice 13 Murphy MR => Howerton TC Ismail H > Wright IK Linn GS = Lifshitz K Murray TK, Cross AJ, Green AR: Reversal Lo ES = Lifshitz K by tetrahydroaminoacridine of scopola- Loschmann P-A, Smith LA, Lange KW, Jackson HC, Dickinson SL, Nutt DJ: Ex- mine-induced memory and_ perfor- Jaehnig P, Jenner P, Marsden CD: Mo- ploring the pharmacology of the pro- mance deficits in rats 134 tor activity following the administration convulsant effects of a2-adrenoceptor Murua VS, Molina VA: Chronic antide- of selective D-1 and D-2 dopaminergic antagonists in mice 558 pressant counteracts the conditioned drugs to normal common marmosets Jaehnig P — Loschmann P-A analgesia induced by a context pre- 303 Jaffe JH > Katz JL viously associated with inescapable Lu X-CM — Genovese RF Jaffe JH — Muntaner C shock 439 Lumeng L — Stewart RB Jenner P > Loschmann P-A Muscat R — Phillips G Joharchi N > Higgins GA Muscat R = Phillips G Johnson D = Clark D Maldonado R, Mico JA, Valverde O, Saa- Muscat R > Stamford JA Nabeshima T > Tohyama K mitted schizophrenics to methylpheni- Soosaar A — Vasar E Nader MA, Woolverton WL: Effects of in- date infusion 247 Spain JW, Newsom GC: Chronic opioids creasing the magnitude of an alternative Rogacki N — Weiss GF impair acquisition of both radial maze reinforcer on drug choice in a discrete- Romanska | > Antkiewicz-Michaluk L and Y-maze choice escape 101 trials choice procedure 169 Rossi-Arnaud C = Fagioli S Srivastava ED, Russell MAH, Feyerabend Nagoshi C > Muntaner C Roth N, Battig K: Effects of cigarette C, Masterson JG, Rhodes J: Sensitivity Newman B = Killen JD smoking upon frequencies of EEG alpha and tolerance to nicotine in smokers Newsom GC = Spain JW rhythm and finger tapping 186 and nonsmokers 63 Nguyen P > Higgins GA Roth WT — Schweizer R Stamford JA, Muscat R, O’Connor JJ, Pa- Niehus DR > Cunningham CL Rowlett JK > Mattingly BA tel J, Trout SJ, Wieczorek WJ, Kruk ZL, Nikulina EM, Skrinskaya JA, Popova NK: Russell MAH — Srivastava ED Willner P: Voltammetric evidence that Role of genotype and dopamine recep- Rusted JM, Eaton-Williams P, Warburton subsensitivity to reward following tors in behaviour of inbred mice in a DM: Acomparison of the effects of sco- chronic mild stress is associated with forced swimming test 525 polamine and diazepam on working increased release of mesolimbic dopa- Nomikos GG, Zis AP, Damsma G, Fibiger memory 442 mine 275 HC: Effects of chronic electroconvul- Steardo L > lovino M sive shock on interstitial concentrations Saavedra MC —> Maldonado R Steenis HG van > Tulen JHM of dopamine in the nucleus accum- Sagratella S, Scotti de Carolis A, Pézzola Steinfels GF — Holtzman SG bens 230 A, Popoli P: Behavioural and electroen- Stewart RB, McBride WJ, Lumeng L, Li Nouth L > Cunningham CL cephalographic interactions between T-K, Murphy JM: Chronic alcohol con- Nutt DJ > Ball DM haloperidol and PCP/sigma ligands in sumption in alcohol-preferring P rats at- Nutt DJ > Glue P the rat 485 tenuates subsequent conditioned taste Nutt DJ — Jackson HC Sanders-Bush E, Breeding M: Choroid aversion produced by ethanol injec- plexus epithelial cells in primary culture: tions 530 Oakley NR, Hayes AG, Sheehan MJ: Ef- a model of 5HT,¢ receptor activation Suh JS > Weiss GF fect of typical and atypical neuroleptics by hallucinoginic drugs 340 Suzuki T, Masukawa Y, Shiozaki Y, Mis- on the behavioural consequences of ac- Sarati S, Guiso G, Garattini S, Caccia S: awa M: Potentiation of pentazocine tivation by muscimol of mesolimbic and Kinetics of piribedil and effects on do- conditioned place preference by tripe- nigro-striatal dopaminergic pathways in pamine metabolism: hepatic biotrans- lennamine in rats 9 the rat 204 formation is not a determinant of its do- Swerdlow NR — Caine SB O'Connor JJ > Stamford JA paminergic action in rats 541 Szabadi E —- Wogar MA O'Keeffe RT — Lifshitz K Schett P > Fleischhacker WW Oliveira RMW de — Audi EA Schulte HM —> Lesch KP Tiplady B > Fagan D Osterheider M > Lesch KP Schweizer R, Roth WT, Elbert T: Effect Tohyama K, Nabeshima T, Ichihara K, Ka- of two 8-blockers on stress during men- meyama T: Involvement of GABAergic tal arithmetic 573 systems in benzodiazepine-induced im- Patel J > Stamford JA Scott DB > Fagan D pairment of passive avoidance learning Petry N — Clark D Scotti de Carolis A > Sagratella S in mice 22 Pézzola A — Sagratella S Seidel WF > Edgar DM Tong Z-Y —> Clark D Phillips G, Willner P, Muscat R: Reward- Seiden LS > Hand TH Trout SJ > Stamford JA dependent suppression or facilitation of Sellers EM > Higgins GA Tulen JHM, Moleman P, Boomsma F, consummatory behaviour by raclo- Sharkey J, McBean DE, Kelly PAT: Alter- Steenis HG van, Heuij VJHM van den: pride 355 ations in hippocampal function follow- Dose-dependent effects of intravenous Phillips G, Willner P, Muscat R: Suppres- ing repeated exposure to the amphet- lorazepam on cardiovascular activity, sion or facilitation of operant behaviour amine derivative methylenedioxymeth- plasma catecholamines and psycholog- by raclopride dependent on concentra- amphetamine (“Ecstasy’’) 113 ical function during rest and mental tion of sucrose reward 239 Sharma H — Khanna JM stress 77 Phillips JP > Fleishaker JC Sharpe LG —> Katz JL Picker MJ, Yarbrough J: Cross-tolerance Sheehan MJ > Oakley NR Ungerer A > Mathis C and enhanced sensitivity to the re- Shiozaki Y > Suzuki T Upton N — Wright IK sponse rate-decreasing effects of Shores El —> Katz JL opioids with varying degrees of efficacy Sills TL, Vaccarino FJ: Facilitation and in- Vaccarino FJ = Sills TL at the mu receptor 459 hibition of feeding by a single dose of Valverde O > Maldonado R Pihl RO > Zacchia C amphetamine: relationship to baseline Varady A — Killen JD Pirke K-M — Wiegand M intake and accumbens cholecystokinin Vasar E, Harro J, Lang A, Péld A, Soosaar Péld A — Vasar E 329 A: Differential involvement of CCK-A Popoli P - Sagratella S Silverstone PH, Grahame-Smith DG: Ef- and CCK-B receptors in the regulation Popova NK > Nikulina EM fects of chronic lithium, amitriptyline, of locomotor activity in the mouse 393 Puglisi-Allegra S + Cabib S and electroconvulsive shock, on calci- Vetulani J — Antkiewicz-Michaluk L um channel binding in a rat brain ho- Ragozzino M —> Walker DL mogenate 132 Wala EP, Martin WR, Sloan JW: Distribu- Rasmussen K, Krystal JH, Aghajanian GK: Skjoldager P, Fowler SC: Scopolamine at- tion of diazepam, nordiazepam, and ox- Excitatory amino acids and morphine tenuates the motor disruptions but not azepam between brain extraneuronal withdrawal: differential effects of cen- the attentional disturbances induced by space, brain tissue, plasma, and cere- tral and peripheral kynurenic acid ad- haloperidol in a sustained attention task brospinal fluid in diazepam and nordia- ministration 508 inthe rat 93 zepam dependent dogs 535 Referees in 1991 583 Skolnick P — Evoniuk GE Walker DL, McGlynn T, Grey C, Ragozzino Rhodes J — Srivastava ED Skrinskaya JA —> Nikulina EM M, Gold PE: Naloxone modulates the Risinger FO > Cunningham CL Sloan JW — Wala EP behavioral effects of cholinergic ago- Robinson D, Mayerhoff D, Alvir J, Cooper Smith LA > Léschmann P-A nists and antagonists 57 T, Lieberman J: Mood responses of re- Smith TC — Fleishaker JC Walsh AE, Ware CJ, Cowen PJ: Lithium Vi and 5-HT,, receptor sensitivity: a neu- Willner P + Stamford JA CA: Effect of isolation rearing on 5-HT roendocrine study in healthy volun- Wilson S > Ball DM agonist-induced responses in the rat teers 568 Wilson S > Glue P 259 Warburton DM —> Rusted JM Winslow JT, Insel TR: Serotonergic mod- Ware CJ = Ellis PM ulation of the rat pup ultrasonic isola- Yarbrough J — Picker MJ Ware CJ — Walsh AE tion call: studies with 5HT, and 5HT2 Young SN = Zacchia C Weiner | > Feldon J subtype-selective agonists and antago- Weiskrantz L, Mondadori C: MK-801 can nists 513 Zacchia C, Pihl RO, Young SN, Ervin FR: facilitate passive avoidance memory Wise RA — Colle LM Effect of sucrose consumption on alco- when retention is not present in control Witkin JM — Katz JL hol-induced impairment in male social animals, and can fail to facilitate when Wogar MA, Bradshaw CM, Szabadi E: Ev- drinkers 49 itis present 145 idence for an involvement of 5-hydrox- Zhu X, McNaughton N: Effects of long- Weiss GF, Rogacki N, Fueg A, Buchen D, ytryptaminergic neurones in the mainte- term administration of imipramine on Suh JS, Wong DT, Leibowitz SF: Effect nance of operant behaviour by positive reticular-elicited hippocampal rhythmi- of hypothalamic and peripheral fluoxe- reinforcement 119 cal slow activity 433 tine injection on natural patterns of Wong CL > Dambisya YM Zis AP — Nomikos GG macronutrient intake in the rat 467 Wong DT — Weiss GF White E > Glue P Woolverton WL — Nader MA Wieczorek WJ — Stamford JA Wozniak DF, Cicero TJ, Kettinger III L, Wiegand M, Bossert S, Kinney R, Pirke Meyer ER: Paternal alcohol consump- K-M, Krieg J-C: Effect of dexfenflura- tion in the rat impairs spatial learning Indexed in Current Contents, mine on sleep in healthy subjects 213 performance in male offspring 289 Psychological Abstracts Willner P — Phillips G Wright IK, Ismail H, Upton N, Marsden and in Psyc INFO Subject index of volume 105 Acetylcholine 57, 310 Attachment behavior 513 CCK—A receptors 393 Acoustic startle response 27 Atypical antidepressants 453 CCK—B receptors 393 Active metabolite 181 Atypical neuroleptics 204 [SH]CGP 12177 283 Acute tolerance 175 Autoreceptors 275 Chlordiazepoxide 22, 197, 253 Adrenoceptor antagonists 563 Chlorprothixene 269 B-adrenoceptors 283, 558 Baseline dependent 329 Choice 169, 355 a,-adrenoceptors 558 Behavior 317, 492 Cholecystokinin 329 Q>-adrenoceptors 368, 558, 563 Behavioral despair test 525 Cholinergic function 400 Aggression 492 Behavioral Pattern Monitor 69 Cholinesterase 400 Aging 481 Behavioral sensitization 501 Choroid plexus 340 Agonist-antagonist opioids 447 Behavioral teratology 289 Chronic antidepressant drugs 439 Alcohol consumption 175 Behaviour 204 Chronic ethanol drinking 530 Alcohol-preferring P rats 530 Benzodiazepine 197, 374, 578 Chronic exposure 400 Alertness 368 Benzodiazepine receptors 361 Chronic mild stress 275 Alpha rhythm 186 Benzodiazepines 1, 535 Chronic treatment 219 Alprazolam 428 B-Blockers 573 Cigarette smoking 63 Amitriptyline 132 Blood pressure 37, 77, 368, 573 Circadian rhythm 374, 467 (+)-Amphetamine 107, 157, 230, 253, Body temperature 84, 374 Circling 157 329, 393 Brain areas 400 Citalopram 269 Amphetamine derivatives 340 Buspirone 428 Clonidine 368 d-Amphetamine 381 CNS 400 Anorexia 329 Caerulein 393 Cocaine 37, 151, 169, 264, 317, 335 Anticholinesterase 400 Caffeine 137 Common marmosets 303 Antidepressant drug 283 Calcium channels 132, 269 Conditioned analgesia 439 Antidepressants 219, 269 Capillary electrophoresis 264 Conditioned locomotor activity 107 Anxiety 513, 578 Carbachol 347 Conditioned place preference 84 Anxiolytic effect 553 Carbohydrate 467 Conditioned suppression 253 Apomorphine 230, 393, 501 Catalepsy 485 Conditioned taste aversion 84, 530 Ataxia 546 Catecholamines 77, 247 w-Conotoxin 132 Vil Continuous performance test 93 GM1 ganglioside 209 3,4-Methylenedioxymethamphetamine Continuous reinforcement 407 Guinea-pig 421 (MDMA) 113 Craving 191 Methylphenidate 247 Cross-tolerance 459 Habituation 13 Metoclopramide 107, 335 Curve shift 355 Hallucinogenic drugs 340 Mianserin 453 Haloperidol 93, 129, 335, 381, 407, Mice 13, 22, 209, 558 Delayed non-match to sample 134 421, 485 Microdialysis 230, 264 ['*C]2-Deoxyglucose 113 Head shakes 219 Midazolam 361 Depression 283 Heart rate 37, 77, 368, 573 MK—801 145, 477 Devazepide 393 Herrnstein’s equation 119 Monkey 492 Development 513 Hillside Akathisia Scale 141 Mono-N-desmethyladinazolam 181 Developmental landmarks 289 Hippocampus 347 Mood response 247 Dexamethasone 481 Hot-plate test 269, 439 Mood state 1 Dexfenfluramine 213 5—HT,, receptor 415 Morphine 57, 253, 447, 508 Diazepam 197, 442, 535 5HT 69 Morphine tolerance 459 5,7-Dihydroxytryptamine 119 5-HT behavioural syndrome 259 Morphine withdrawal 197 Discriminative-stimulus effects 317 5-HT receptor subtypes 219 Motor activity 374 Dissociative anesthetics 125 5—HT receptors 553 Mouse 525, 546 Dizocilpine 421 5—HT, receptors 453 Mouse brain 310 Dizolcipine 125 5—HT, receptor 322 Mu opioids 459 DM-9384 310 5—HT,, receptors 568, 578 Muscimol 204 Dopamine 151, 230, 264, 347 5HT,¢ receptors 340 Dopamine D, receptor 9 Human volunteer 129 Naloxone 57 Dopamine receptor blockers 225 5-Hydroxytryptamine 113, 119 Naltrexone 447 Dopamine receptors 335 Hyperactivity 335 NANM 421 Dopamine release 275 Neuroendocrine 568 Dopaminergic system 541 Idazoxan 368 Neuroleptic-induced akathisia 141 DRL 72-s schedule 453 Imipramine 269, 433 Neurotoxicity 113 Drug discrimination 447 Impulsivity 137 Nicotine 186 Drug induced akathisia 141 Individual differences 329 Nicotine pharmacokinetics 63 DTG 421 Indolealkylamines 340 Nicotine tolerance 63 D1 and D2 dopamine receptors 525 Inescapable shock 439 Nifedipine 37 D-1 receptors 303 Infant rats 513 Nigro-striatal 204 D-2 receptors 303 Inhalation 317 Nitrazepam 197 Initial sensitivity 175 [SH]Nitrendipine 269 EEG 186, 485 Instrumental learning 407 NMDA 145 Efficacy 459 Interrater reliability 141 NMDA receptor 546 Electroconvulsive shock 132, 230 Intoxication 49 Noradrenaline 558 Electroshock seizure threshold 558 Intracerebral microdialysis 535 Nordiazepam 535 Elevated plus-maze 553 Ipsapirone 415 Nucleus accumbens 157, 230, 264, 329 Emotionality 209 Isolation rearing 259 Enhanced sensitivity 459 Obsessive-compulsive disorder 415 Ethanol 49 Ondansetron 322 Ethanol drinking 84 Kappa opioid 447 Open field 209 Ethanol sensitivity 13 Ketamine 162, 421 Operant behavior 477 Ethanol tolerance 13 Kinetics 541 Operant behaviour 119 Excitatory amino acid 145, 508 Kynurenic acid 508 Operant performance 239 Extinction 407 Opiate withdrawal 508 Extraneuronal brain space levels 535 Learning 101 Opiates 57 Learning and memory 289 Opioid antinociception 563 Feeding 329 Lidocaine 264 Opioid withdrawal 322 d-Fenfluramine 129 Light 374 Opioids 101 Finger tapping 186 Lithium 132, 568 Organophosphate 400 Fixed-ratio schedule 151 Locomotor activity 57, 69, 84, 303, 393, Oxiracetam 310 Flumazenil 361 501 Flunitrazepam 197 Locomotor hyperactivity 381 Paraventricular nucleus 467 Fluoxetine 415, 467 Locus coeruleus 508 Paroxetine 113 Flupentixol 42 Lorazepam IV 77 Partial D2 dopamine agonists 381 Fluphenazine 492 Low-dose 400 Partial reinforcement extinction effects Free plasma levels 535 Lower lip retraction 219 407 Functional interaction 303 LSD 69 Passive avoidance 145 L—365,260 393 Passive avoidance response 22 GABA 13 Paternal alcohol 289 GABA agonist 22 MDL 72222 322 PCP/sigma ligands 485 GABA antagonist 22 Memory 1,57, 442, 521, 546 Penile erections 219 Generalized anxiety disorder 428 Memory effects 181 Pentazocine 9, 421 Genetics 13 Memory facilitation 145 Peptide 546 Genotype 525 Mental arithmetic 573 Performance tasks 77 Gepirone 568 Mesolimbic 204 Periaqueductal gray 553 Glucose 521 Metabolism 541 Perphenazine 42 Glycine 125 Metergoline 129 Personality 137 Vil Pharmacokinetics 42 Ritanserin 69, 553 (—)-Sulpiride 335, 501 Phencyclidine 125, 447 Rolipram 27 Suprachiasmatic nucleus 467 Phosphodiesterase 27 Route of administration 317 Sustained attention 93 Phosphoinositide hydrolysis 340 Sweet reward 239 Physostigmine 57, 134, 310 Saccadic eye movements 361, 368 Sweetness 355 Pigeons 253, 459 Schedule controlled responding 459 Sympathomimetics 563 Piribedil 541 Schizoaffective disorder 247 Place aversion 322 Schizophrenia 42, 162, 247, 347 Tacrine 310 Place preference 9 SCH 23390 9, 107, 151, 335, 501 Tardive dyskinesia 492 Placebo 428 Scopolamine 57, 93, 134, 310, 442 Tardive pathology 492 PN 200—110 132 Secondary cues 239 Temperature 568 Postmortem human brain 283 Sedation 1, 181, 368 Tetrahydroaminoacridine 134 Potentiation 9, 563 Seizure 546 Therapeutic window 42 Prepulse inhibition 162, 347 Selective a,-adrenoceptor antagonists Thyrotropin stimulating hormone (TSH) Procaine 169, 264 558 481 Progressive-ratio schedule 151 Self-administration 151, 169 Thyrotropin-releasing hormone (TRH) Prolactin 129 Semantic task 137 481 Propranolol 69, 553 Sensorimotor gating 347 Time course 400 Prospective study 191 Serotonin 69, 213, 340, 453, 467, 513 Tobacco dependence 191 Protein 467 Serotonin agonists 340 Tolerance 101, 477, 530 Psychological performance 225 Sigma receptors 125 Total brain levels 535 Psychomotor effects 181 SKF 38393 107 Total plasma levels 535 Psychostimulants 247 Sleep 374 Transdermal nicotine 63 Sleep deprivation 374 Tremors 57 Quinpirole 107 Sleep EEG 213 Triazolam 197, 374 Smoking 186 Tripelennamine 9 Raclopride 239, 355 Soman 400 Typical neuroleptics 204 Radial arm maze 101, 289 Spatial learning 209 Rat 9, 27, 69, 93, 113, 119, 129, 134, Spiperone 151 145, 157, 162, 175, 219, 239, 259, Spiradoline 447 Validity 141 275, 322, 329, 355, 381, 407, 433, Spontaneous locomotor activity 259 Vocalization 513 477, 541, 553 Squirrel monkeys 317 Voltammetry 275 Rate-dependency 253 Startle 347 Reaction time 93 Stereotypy 381 Win-stay/T-maze 289 Recall 137 Stimulus-effector coupling 381 Withdrawal 578 REM sleep 374 Stress 492, 573 Withdrawal syndrome 322 Remoxipride 225, 421 Subjective mood 77 Working memory 101 Reticular-elicited hippocampal rhythmical Sucrose 49 slow activity 433 Sucrose reward 275 Rhesus monkey 169 Sugar 329 Y-maze choice escape 101 Rhyming task 137 Suicide 283 Young adult humans 521